The largest database of trusted experimental protocols

Zorbax 80sb 5 μm c18 phase

Manufactured by Agilent Technologies
Sourced in Germany

The Zorbax 80SB 5 μm C18 phase is a reversed-phase high-performance liquid chromatography (HPLC) column. It features a silica-based stationary phase with a particle size of 5 micrometers and a pore size of 80 angstroms. This column is designed for a variety of analytical and preparative applications.

Automatically generated - may contain errors

3 protocols using zorbax 80sb 5 μm c18 phase

1

Quantitative Analysis of Dexfenfluramine and Pergolide in Rabbit Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dexfenfluramine and pergolide concentrations in rabbit serum were determined by liquid chromatography coupled with mass spectrometry (LC–Chip–MS/MS). Briefly, the chromatographic separation was achieved on a 1200 series LC-chip system (Agilent Technologies, Germany) using an Ultra High Capacity chip including a 500 nL trapping column and a 150 mm × 75 μm analytical column, both packed with a Zorbax 80SB 5 μm C18 phase (Agilent Technologies). The mobile phase was composed of H2O/FA (100:0.1, v/v) (A) and ACN/H2O/FA (90:10:0.1, v/v/v) (B) and used in gradient elution mode (from 15% to 69% B in 5 min). Mass spectrometric detection was performed using a 6340 Ion Trap equipped with a nanoelectrospray ionization source operating in positive mode (Agilent Technologies, Waldbronn) (transitions followed for dexfenfluramine: 232.0 −> 158.8; 186.8 m/z and for pergolide: 315.2 −> 207.9; 267.0 m/z). Finally, an Oasis µElution MCX 96-well plate (Waters, UK) was used to prepare the samples for the analysis. Fifty microliters of plasma was needed per experiment and all conditions were performed in duplicate and back-calculated using a calibration curve.
+ Open protocol
+ Expand
2

LC-Chip-MS/MS Quantification of Fluoxetine and Norfluoxetine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug concentrations were determined from serum using liquid chromatography coupled with mass spectrometry (LC-Chip-MS/MS) that was used as previously described [22 (link), 33 , 34 (link)]. Briefly, the chromatographic separation was achieved on a 1200 series LC-chip system (Agilent Technologies, Germany) using an ultrahigh capacity chip including a 500 nL trapping column and a 150 mm × 75 μm analytical column, both packed with a Zorbax 80SB 5 μm C18 phase (Agilent Technologies). The mobile phase was composed of H2O/FA (100 : 0.1, v/v) (A) and ACN/H2O/FA (90 : 10 : 0.1, v/v/v) (B) and used in gradient elution mode. Mass spectrometric detection was performed using a 6340 ion trap equipped with a nanoelectrospray ionization source operating in positive mode (Agilent Technologies, Waldbronn). Finally, an Oasis μElution MCX 96-well plate (Waters, UK) was used to prepare the samples for the analysis. All conditions were performed in duplicate and back-calculated using a calibration curve. Fluoxetine and norfluoxetine levels were averaged across days to provide one morning and one afternoon value.
+ Open protocol
+ Expand
3

Quantification of Fluoxetine and Metabolite

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine serum fluoxetine and norfluoxetine concentrations in dams, liquid chromatography coupled with mass spectrometry (LC-MS/ MS) was used as described [41, 50, 51, 54] . The chromatographic separation was achieved using an Ultra High Capacity chip including a 500 nL trapping column and a 150 mm × 75 μm analytical column, both packed with a Zorbax 80SB 5 μm C18 phase (Agilent Technologies) on a 1200 series LC-chip system (Agilent Technologies, Germany). The mobile phase was composed of H2O/FA (100:.1, v/v) (A) and ACN/ H2O/FA (90:10:.1, v/v/v) (B) which were used in gradient elution mode. Mass spectrometric detection was carried out using a 6340 Ion Trap consisting of a nanoelectrospray ionization source operating in positive mode (Agilent Technologies, Waldbronn). An Oasis μElution MCX 96-well plate (Waters, UK) was used to prepare the samples for the analysis. All conditions were performed in duplicate and back-calculated using a calibration curve. Twenty-five μL of serum was needed per animal. Mean ( ± SEM) medication levels for the dams at sacrifice were 19.3 ± 6.7 ng/ml for fluoxetine and 110.1 ± 26.1 ng/ml for norfluoxetine (n = 13 treated dams).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!